Cardiovascular disease (CVD) remains the top cause of illness and early death worldwide, especially in developing regions. New research highlights that shifts in estimated glucose disposal rate (eGDR) over time greatly affect the risk of developing CVD, which makes tracking this health metric especially valuable. Studies using extensive data from resources like the UK Biobank and the China Health and Retirement Longitudinal Study (CHARLS) underline that monitoring eGDR can reveal changes in heart health and support early intervention.
By actively tracking eGDR, healthcare brands can develop tools and strategies that support heart health and reduce CVD risks. This approach is especially meaningful in creating targeted, data-driven solutions that cater to individual needs. Through collaboration and innovative health solutions, we’re making strides toward a future that’s healthier and more preventive. These advancements show that by leveraging the power of data, we’re setting the stage for impactful change in cardiovascular health, benefiting communities around the globe.
Source: cardiab.biomedcentral.com/articles/10.1186/s12933-024-02485-8
